In order to increase the accuracy of SMN1 and SMN2 copy number determination by ddPCR, we 15 adopted and optimized a method based on extreme value theory for threshold estimation. Our 16 method increases total accuracy and improves resolution of problematic samples. 
Abstract

1
Spinal muscular atrophy (SMA) is the most frequent genetic cause of infantile death. 2 Homozygous deletion screening of survival of motor neuron (SMN1) represents the first tier in 3 diagnostic testing. In this work, we adopted and optimized a method to increase the accuracy of 4 SMN1 and SMN2 copy number determination on ddPCR platform. This method, which makes 5 no assumption about the distribution of the fluorescence readouts, was shown to significantly 6 increase accuracy and outperform QuantaSoft software on problematic SMN1 samples. 7 8 9
Main Body
10
Spinal muscular atrophy (SMA), an autosomal recessive neuromuscular disorder characterized 11 by progressive loss of motor neurons in the spinal cord 1, is the most common cause of early 12 childhood death (2,3). The homozygous deletion or mutation in the survival of motor neuron 13 (SMN1) gene has been observed in the majority of SMA patients 4, but all patients retain a 14 centromeric copy of the gene, SMN2 5. Since SMA is a severe disease with a high carrier 15 frequency, direct carrier dosage testing has been beneficial to many families 6. Quantitative 16 methods of SMN dosage use real-time PCR 7, but many factors can impact PCR efficiency and 17 hence the threshold cycle, affecting accuracy and precision 8. Currently, the droplet digital PCR 18 system of Bio-Rad is a widely used ddPCR platform. However, the threshold setting method in 19
QuantaSoft software (Bio-Rad Laboratories, Inc., Hercules, CA, USA) that comes with the 20 ddPCR platform is not always accurate as the threshold often falls within the population of 21 negative droplets or is not possible to calculate. This leads to inaccuracies in copy number 22 determination for SMN1 and SMN2. In this paper, we adopted and optimized the method 23 described in 9 to estimate the threshold which is needed to determine copy numbers of SMN1 24 and SMN2. The method does not make any assumptions about the distribution of the 25 fluorescence readouts and estimates the threshold by modelling the extreme values in the 26 negative droplet population using extreme value theory. Moreover, this method takes into 27 account shifts in baseline fluorescence between samples. 28
Clinical samples from a commercial carrier screening platform (CarrierMap, Recombine, Inc.) 29 were used after previously failing SMA testing in an internal qPCR assay 10 and commercial 30 ddPCR assay (Bio-Rad catalog number 1863500), respectively. These samples were sent to a 31 CAP/CLIA laboratory (Athena Diagnostics Inc., Marlborough, MA, USA) for unequivocal 32 SMN1 and SMN2 analysis. If a sample failed the ddPCR assay for any reason (<10,000 droplets, 33 <100 copies/uL, too much "rain" to create a confident threshold, or a copy number outside of 0.2 34 copies from a whole number), it was noted as a failure and was not assigned a copy number.
35
Some samples failed multiple times in the ddPCR assay with inconsistent results, were labeled as 36 "problematic" samples and no copy number was obtained from ddPCR testing. Sample data was 37 then exported from the QuantaSoft software to perform the analysis method discussed in this 1 paper. A previously presented method 9, which makes no assumptions about the distribution of 2 the fluorescence readouts was adopted and optimized to determine copy numbers of SMN1 and 3 SMN2. This method relies on application of generalized extreme value (GEV) distribution for 4 estimating a threshold that segregates positive and negative droplets in ddPCR systems. The raw 5 data in no template controls (NTCs) are first normalized to correct for variations among NTCs. 6
Robust mode estimator suggested by Robertson and Cryer 11 is applied to each NTC to obtain a 7 stable estimate of measure of central tendency, which does not require any parameters to be set 8 and is not dependent on the amount of rain. After subtracting the estimated robust mode from all 9 measured intensities of each NTC, all the NTCs are merged to represent a single sample from the 10 population of negative droplets 9. This normalization procedure by subtracting robust mode is 11 applied even if there is only one NTC available. 12
To fit GEV distribution to fluorescence intensity values, the sample is divided to blocks of 13 subsamples and the distribution parameters are calculated by fitting to the maxima of the blocks. 14 These parameters and an initial threshold, , predetermined percentile of the fitted distribution, 15 are used to obtain the threshold relative to normalized NTCs. We then need a raw threshold to 16 classify negative and positive droplets, which can be obtained by averaging the robust modes of 17 the NTCs and adding the threshold related to the NTCs. Then, after estimating the robust mode, 18 it will be added to the previously calculated threshold (related to the NTCs) to obtain the final 19 threshold of the sample. 20
Using the final threshold, positive and negative droplets can be classified and the concentration, 21
, is calculated as 9: 22 = − *+, × 1000
× 23
where V 4 is 0.91 µL and D is dilution factor as described in 8. Finally, copy number is calculated 24 as the ratio of the target molecule concentration to the reference molecule concentration, 25 multiplied by the number of copies of reference species in the genome: 26
where 6 is concentration of target species, 7 is concentration of reference species, and is a 28 ratio which is considered as the number of copies of reference loci in the genome and is usually 29 set as 2. However, since 6 and 7 are not necessarily obtained at the same speed and other 30 identical conditions, we considered this value as a parameter to be estimated. 31
This method requires appropriate values for number of blocks , initial threshold , and the ratio 32
. In order to estimate these parameters for SMN1 and SMN2, we used validation samples (384 33 SMN1 and 288 SMN2) measured in an external CAP/CLIA laboratory. In this work, we adopted ddpcRquant method which estimates the threshold by modeling the 12 extreme values in the negative droplet population using extreme value theory while no 13 assumptions are made about the distribution of the fluorescence readouts. We then optimized the 14 parameter sets for SMN1 and SMN2 separately to determine their copy numbers. The results 15
show that this method significantly outperforms QuantaSoft software in determining the copy 16 numbers of SMN1 problematic/flagged samples. Future work is combining this method with 17 other technologies to further increase the accuracy of copy number determination. 
